CWBR CohBar
- 0.880
- +0.120+15.77%
CohBar News
Liver Disease Drug Developers Rise After Gilead-CymaBay M&A Deal
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers180 Life Sciences (NASDAQ:ATNF) shares rose 38.2% to $0.47 during Tuesday's after-market session. The company's market cap stands at $3.4 million. Redhill Biopharma (NASDAQ:RDHL) shares rose 23
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAvidity Biosciences (NASDAQ:RNA) shares rose 38.1% to $8.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $630.6 million. Heart Test Laboratories (NASD
CohBar Announces Nasdaq's Notice of Delisting; Does Not Plan to Request Hearing
CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.MENLO PARK, Calif.--(BUSINESS WIRE)--On November 20, 2023, CohBar, Inc. (the "Company") wa
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.67%
Why CohBar (CWBR) Stock Is Down Nearly 50% Today
CohBar Inc (NASDAQ:CWBR) shares are trading lower by 47% to $0.92 Wednesday afternoon. The stock is falling sharply after the company received guidance from Nasdaq that the company and Morphogenesis,
SLN, EKSO and BANL Among Mid-day Movers
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersCellectis (NASDAQ:CLLS) shares moved upwards by 188.6% to $2.8 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 58.7 million, which is 110697.6% of its av
G1 Therapeutics, BioXcel Therapeutics Among Healthcare Movers
CohBar Shares Slide to New Depths on Plans to Liquidate
By Colin Kellaher CohBar shares plunged to a new all-time low on Wednesday after the biotechnology company said it plans to dissolve following the termination of a planned reverse merger with private
CohBar Says It Intends To Commence Process Of Liquidating And Dissolving Itself In Accordance With Its Organizational Documents And Applicable Law
CohBar Says It Intends To Commence Process Of Liquidating And Dissolving Itself In Accordance With Its Organizational Documents And Applicable Law
CohBar Says On Nov 1, Got Termination Notice From Morphogenesis, Effective Nov 1 And Merger Agreement Was Terminated In Accordance With Terms
CohBar Says On Nov 1, Got Termination Notice From Morphogenesis, Effective Nov 1 And Merger Agreement Was Terminated In Accordance With Terms
CohBar Says On Oct 31, Board Determined There Was Not Viable Path Forward To Consummate Merger Primarily Due To Oral Guidance Received From Nasdaq
CohBar Says On Oct 31, Board Determined There Was Not Viable Path Forward To Consummate Merger Primarily Due To Oral Guidance Received From Nasdaq
Akero Plummets After Mid-stage Data for NASH Candidate
12 Health Care Stocks Moving In Monday's After-Market Session
GainersLongeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares moved upwards by 536.4% to $0.01 during Monday's after-market session. At the close, Longeveron Inc. - Subscription Right's trading vo
CohBar GAAP EPS of -$1.49
CohBar Q2 EPS $(1.49) Down From $(0.90) YoY
CohBar (NASDAQ:CWBR) reported quarterly losses of $(1.49) per share. This is a 65.56 percent decrease over losses of $(0.90) per share from the same period last year.
Press Release: CohBar Reports Second Quarter 2023 Financial Results
CohBar Reports Second Quarter 2023 Financial Results MENLO PARK, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) today reported its financial results and highlights for the seco
Cohbar 2Q Loss/Shr $1.49 >CWBR
Cohbar 2Q Loss/Shr $1.49 >CWBR
Analysis
Price Target
No Data
